RIKEN researchers have discovered how an enzyme modifies gene expression by targeting certain stretches of messenger RNA ...

European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...

医薬品受託製造のARCALIS（アルカリス、福島県南相馬市）は27日、メッセンジャーRNA（mRNA）の製剤工場を福島県南相馬市に竣工したと発表した。年間3200万回分のmRNA医薬品を製造する能力をもつ。既存の工場などと合わせ、mRNA医薬品の研究 ...

Vaccines made with messenger RNA can be made quicker to adapt to new strains of viruses. Vaccines made with messenger RNA can ...

In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions ...

Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

The recommendation from regulators paves the way for the shot’s approval in the European Union at a time the company is ...

Emerging modalities such as self-amplifying and circular RNA, expanding oncology and rare-disease applications, and scalable manufacturing are creating high-growth investment avenues, supported by ...

Messenger RNA (mRNA) technology is transforming medicine by providing our cells with genetic instructions to produce ...